Risk Prediction for Early Mortality in Patients with Newly Diagnosed Primary CNS Lymphoma

Background: Overall survival of patients with primary CNS lymphoma (PCNSL) has improved since the introduction of immunochemotherapy. However, up to 10-15% of PCNSL patients still die shortly after diagnosis. In the present study, we aimed to investigate the risk factors of early mortality (death wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chia-Hsin, Yang, Ching-Fen, Yang, Huai-Che, Fay, Li-Yu, Yeh, Chiu-Mei, Kuan, Ai-Seon, Wang, Hao-Yuan, Gau, Jyh-Pyng, Hsiao, Liang-Tsai, Chiou, Tzeon-Jye, Chen, Po-Min, Liu, Yao-Chung, Ko, Po-Shen, Liu, Jin-Hwang, Liu, Chia-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692612/
https://www.ncbi.nlm.nih.gov/pubmed/31417640
http://dx.doi.org/10.7150/jca.32467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692612/
https://www.ncbi.nlm.nih.gov/pubmed/31417640
http://dx.doi.org/10.7150/jca.32467

Ejemplares similares